CytomX Therapeutics (CTMX) Asset Utilization Ratio (2016 - 2025)
Historic Asset Utilization Ratio for CytomX Therapeutics (CTMX) over the last 11 years, with Q3 2025 value amounting to 0.68.
- CytomX Therapeutics' Asset Utilization Ratio fell 1970.98% to 0.68 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.68, marking a year-over-year decrease of 1970.98%. This contributed to the annual value of 0.86 for FY2024, which is 9586.29% up from last year.
- According to the latest figures from Q3 2025, CytomX Therapeutics' Asset Utilization Ratio is 0.68, which was down 1970.98% from 1.03 recorded in Q2 2025.
- In the past 5 years, CytomX Therapeutics' Asset Utilization Ratio ranged from a high of 1.35 in Q1 2025 and a low of 0.07 during Q1 2021
- Over the past 5 years, CytomX Therapeutics' median Asset Utilization Ratio value was 0.36 (recorded in 2023), while the average stood at 0.47.
- Per our database at Business Quant, CytomX Therapeutics' Asset Utilization Ratio crashed by 4657.69% in 2021 and then surged by 14247.62% in 2023.
- Quarter analysis of 5 years shows CytomX Therapeutics' Asset Utilization Ratio stood at 0.11 in 2021, then skyrocketed by 107.75% to 0.22 in 2022, then soared by 119.38% to 0.48 in 2023, then skyrocketed by 122.38% to 1.06 in 2024, then plummeted by 35.94% to 0.68 in 2025.
- Its last three reported values are 0.68 in Q3 2025, 1.03 for Q2 2025, and 1.35 during Q1 2025.